A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML
Kura Oncology, Inc.
Kura Oncology, Inc.
Eastern Cooperative Oncology Group
Essen Biotech
Fred Hutchinson Cancer Center
University of Nebraska
Adela, Inc
University of Arizona
UNC Lineberger Comprehensive Cancer Center
Young Adult Survivors United
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Washington University School of Medicine
Masonic Cancer Center, University of Minnesota
City of Hope Medical Center
Masonic Cancer Center, University of Minnesota
Children's Oncology Group
University Medical Center Groningen
Tempus AI